Iwai Yoshiyasu, Yamanaka Kazuhiro, Yoshioka Kastunobu, Yoshimura Masaki, Honda Yuji, Matsusaka Yasuhiro, Komiyama Masaki, Yasui Toshihiro
Department of Neurosurgery, Osaka City General Hospital, Japan.
No Shinkei Geka. 2005 Aug;33(8):777-83.
We evaluated the treatment results of nonfunctioning pituitary adenomas in the era of radiosurgery. Between January 1994 and December 2003, we operated on 44 patients with nonfunctioning pituitary adenomas. 43 patients were operated on by transsphenoidal surgery and one patient was operated on by the transcranial approach. Total removal was able to be achieved in 13 patients (30%). Gamma knife radiosurgery was performed for residual tumor in 26 patients and for recurrence in 2 patients. The mean tumor diameter at the gamma knife radiosurgery was 18.2 mm (7.9 to 26.3 mm). The treatment dose was a mean of 12.3 Gy (8 to 16 Gy) to the tumor margin. The mean follow-up period after radiosurgery was 36.4 months. Tumor growth control was able to be achieved in 26 patients (93%). Two patients (7%) required adrenal and thyroid hormonal replacement during the follow-up period after radiosurgery due to radiation-induced endocrinopathy. None of the patients suffered from new cranial nerve deficits. This included optic neuropathy. Surgical resection using transsphenoidal surgery and subsequent gamma knife radiosurgery for residual and recurrent tumor proved to have a highly effective tumor growth control rate, and maintained the quality of life in patients with nonfunctioning pituitary adenomas.
我们评估了放射外科时代无功能垂体腺瘤的治疗效果。1994年1月至2003年12月期间,我们对44例无功能垂体腺瘤患者进行了手术。43例患者接受经蝶窦手术,1例患者接受经颅手术。13例患者(30%)实现了肿瘤全切。26例患者因残留肿瘤接受了伽玛刀放射外科治疗,2例患者因复发接受了该治疗。伽玛刀放射外科治疗时肿瘤的平均直径为18.2毫米(7.9至26.3毫米)。肿瘤边缘的治疗剂量平均为12.3 Gy(8至16 Gy)。放射外科治疗后的平均随访期为36.4个月。26例患者(93%)实现了肿瘤生长控制。2例患者(7%)在放射外科治疗后的随访期因放射性内分泌病需要肾上腺和甲状腺激素替代治疗。没有患者出现新的颅神经缺损,包括视神经病变。经蝶窦手术切除肿瘤,随后对残留和复发肿瘤进行伽玛刀放射外科治疗,被证明具有很高的肿瘤生长控制率,并维持了无功能垂体腺瘤患者的生活质量。